These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18295026)

  • 1. Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea.
    Philips M; Zachariah R; Venis S
    Lancet; 2008 Feb; 371(9613):682-684. PubMed ID: 18295026
    [No Abstract]   [Full Text] [Related]  

  • 2. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV/AIDS workforce development in sub-Saharan Africa: leveraging opportunity for long-term human development.
    Zuniga JM
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(1):5-9. PubMed ID: 20071591
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?
    Kouamé G; Danel C; Moh R; Badjé A; Jean K; N'takpe JB; Gabillard D; Le Carrou J; du Loû AD; Deschamps N; Eholie S; Anglaret X
    AIDS; 2014 Jun; 28(10):1533-5. PubMed ID: 24804862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 6. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating global health worker shortages: task shifting and sharing may provide one solution.
    Nelson R
    Am J Nurs; 2012 Dec; 112(12):17-8. PubMed ID: 23190658
    [No Abstract]   [Full Text] [Related]  

  • 8. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 9. Bottlenecks to HIV care and treatment in sub-Saharan Africa: a multi-country qualitative study.
    Wringe A; Renju J; Seeley J; Moshabela M; Skovdal M
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736397
    [No Abstract]   [Full Text] [Related]  

  • 10. Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition.
    Grimsrud A; Ford N; Myer L
    Trop Med Int Health; 2011 Mar; 16(3):390-1; author reply 392. PubMed ID: 21143352
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence without access to antiretroviral therapy in sub-Saharan Africa?
    Bangsberg DR; Ware N; Simoni JM
    AIDS; 2006 Jan; 20(1):140-1; author reply 141-2. PubMed ID: 16327340
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic review evaluating the impact of task shifting on access to antiretroviral therapy in sub-Saharan Africa.
    Emdin CA; Millson P
    Afr Health Sci; 2012 Sep; 12(3):318-24. PubMed ID: 23382746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
    Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
    Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step.
    Laurent C
    J Public Health Policy; 2010 Dec; 31(4):401-6. PubMed ID: 21119647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-supported models of care for people on HIV treatment in sub-Saharan Africa.
    Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N
    Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
    Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
    Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.